哈藥股份(600664.SH):擬向多家銀行申請不超5億元中短期信用貸款
格隆匯 9 月 11日丨哈藥股份(600664.SH)公佈,公司第八屆三十四次董事會決議,審議通過關於申請銀行貸款的議案。
鑑於目前市場環境及公司經營性資金需求,為保證公司各項生產經營工作的持續穩健發展,公司擬通過優化資本結構,利用銀行貸款來滿足經營所需流動資金的使用。公司擬向多家銀行申請不超過5億元中短期信用貸款,最終利率以銀企雙方簽署的《貸款合同》相關條款約定為準。
經審議,公司董事會同意上述貸款事宜,同意授權管理層辦理本次貸款的具體手續並簽署相關協議或合同文件。
該議案尚需提交公司股東大會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.